Active Ingredient: NAPROXEN
Proprietary Name: NAPROXEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A212517
Product Number: 001
Approval Date: Feb 21, 2020
Applicant Holder Full Name: SCIEGEN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information